Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02XYB
|
||||
Former ID |
DIB002353
|
||||
Drug Name |
SARIPIDEM
|
||||
Synonyms |
SL-85.0274; Saripidem < Rec INN >; N-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-3-ylmethyl]-N-methylbutanamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] | Phase 2 | [525986] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H20ClN3O
|
||||
Canonical SMILES |
CCCC(=O)N(C)Cc1c(nc2ccccn12)c3ccc(Cl)cc3
|
||||
InChI |
1S/C19H20ClN3O/c1-3-6-18(24)22(2)13-16-19(14-8-10-15(20)11-9-14)21-17-7-4-5-12-23(16)17/h4-5,7-12H,3,6,13H2,1-2H3
|
||||
InChIKey |
LIFDPEORUVTOCP-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 103844-86-6
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | GABA A receptor | Target Info | Modulator | [525986] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.